Samith T. Kochuparambil - Publications

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

Journal: Nature communications

Published: July 25, 2025

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.

Journal: Nature communications

Published: February 28, 2025

Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial.

Journal: BMJ open

Published: September 14, 2022

Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.

Journal: Head & neck

Published: March 03, 2021

Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC).

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: June 03, 2020

Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.

Journal: JAMA oncology

Published: January 04, 2019

Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.

Journal: Cancer medicine

Published: September 24, 2014

Sarcoidosis presenting with pancytopenia.

Journal: The American journal of medicine

Published: May 22, 2014

Novel antibody therapy in acute lymphoblastic leukemia.

Journal: Current hematologic malignancy reports

Published: March 14, 2014

Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies.

Journal: Bone marrow transplantation

Published: January 08, 2013

Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis.

Journal: BMC cancer

Published: April 14, 2012

Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization.

Journal: Journal of oncology

Published: December 21, 2011